Insider filing · ONC
Lai Wang
President, Global Head of R&D
profile →
BeOne Medicines AG
ONC · Healthcare · 70 filings in 24 months
ticker →
Lai Wang sold $1.1M of BeOne Medicines AG (ONC)
Executed Jul 29 2025, disclosed Jul 31 2025, 2 days later.
Value, as filed
$1.1M
3,749 sh across 2 lots
Executed
Jul 29 2025
the trade date, as filed
Disclosed
Jul 31 2025
2 days after the trade
Return, 21 sessionsiFrom the disclosed entry session; derived
–
purchases only
Returns are measured on stock purchases only.
The filer
LWLai Wang (President, Global Head of R&D) filed 4 Form 4 reports in the trailing twelve months (0 purchases, 4 sales), most often in BeOne Medicines AG (ONC). The largest single filing was $357K of ONC (1,327 sh × $269.34, as filed), executed Jun 8.
The name
ONCHealthcare · BeOne Medicines AG, an oncology company, engages in discovering and developing various treatments for cancer patients in the United States,…
More Healthcare filings→ Insider filings, newest first→ View the original filing at www.sec.gov→Other filings by Lai Wang in ONC
ONCSALE
BeOne Medicines AG
$296K1,068 sh × $276.74
Exec Jun 23
Filed Jun 25 · 5:30 PM ET ONCSALE BeOne Medicines AG $310K
1,169 sh × $265.39
Exec Jun 16
Filed Jun 18 · 5:30 PM ET ONCSALE BeOne Medicines AG $197K
756 sh × $261.00
Exec Jun 11
Filed Jun 15 · 5:30 PM ET ONCSALE BeOne Medicines AG $357K
1,327 sh × $269.34
Exec Jun 8
Filed Jun 10 · 5:30 PM ET ONCSALE BeOne Medicines AG $1.8M
5,000 sh × $350.06
Exec Sep 9 2025
Filed Sep 11 2025 · 5:30 PM ET ONCSALE BeOne Medicines AG $210K
700 sh × $300.00
Exec Jul 18 2025
Filed Jul 22 2025 · 5:30 PM ET ONCSALE BeOne Medicines AG $267K
1,028 sh × $260.00
Exec Jun 23 2025
Filed Jun 25 2025 · 5:30 PM ET ONCSALE BeOne Medicines AG $432K
1,647 sh across 2 lots
Exec Jun 16 2025
Filed Jun 18 2025 · 5:30 PM ET